| Literature DB >> 11981881 |
Abstract
Drug discovery efforts rely increasingly on the identification of quality lead compounds through high-throughput synthesis and screening. However, large-scale random libraries have yielded only a low number of quality lead molecules. To address this shortcoming researchers have paid more attention to the concept of "drug-likeness" of molecules in combinatorial and screening libraries. Database profiling and analysis methods have been employed to identify the structural features of known drug molecules. Neural networks and machine learning methods help to distinguish between drugs and nondrugs. More recently, database-independent pharmacophore filters have been introduced that provide simple intuitive rules to classify potential drugs.Mesh:
Year: 2002 PMID: 11981881 DOI: 10.1002/1521-3765(20020503)8:9<1976::AID-CHEM1976>3.0.CO;2-K
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236